Archive | Bachem AG

Home / Archive

Bachem offering CART peptides for drug addiction studies

Bachem offering CART peptides for drug addiction studies

Wednesday 24th March 2021

By Bachem AG Learn More >

Bachem hosting webinar on Solubility-directed Development of Trileucine process

Bachem hosting webinar on Solubility-directed Development of Trileucine process

Tuesday 16th March 2021

By Bachem AG Learn More >

Bachem showcasing well-stocked development pipeline at INTERPHEX Osaka

Bachem showcasing well-stocked development pipeline at INTERPHEX Osaka

Tuesday 16th February 2021

By Bachem AG Learn More >

Bachem hosting webinar on Peptide Easy Clean (PEC) technology

Bachem hosting webinar on Peptide Easy Clean (PEC) technology

Thursday 11th February 2021

By Bachem AG Learn More >

Bachem to host microspheres peptide delivery webinar

Thursday 14th January 2021

By Bachem AG Learn More >

Bachem publishes White Paper on Microspheres and Nanoparticles

Tuesday 24th November 2020

By Bachem AG Learn More >

48451Oligonucleotides @ Bachem – Interview with Torsten Wöhr

Oligonucleotides @ Bachem – Interview with Torsten Wöhr

Tuesday 10th November 2020

By Bachem AG Learn More >

Bachem reports accelerated growth for first half 2020

Bachem reports accelerated growth for first half 2020

Wednesday 30th September 2020

By Bachem AG Learn More >

Bachem reveals impressive growth figures behind award nomination

Bachem reveals impressive growth figures behind award nomination

Friday 28th August 2020

By Bachem AG Learn More >

Bachem Nominated for Swiss Biotech Success Story Award 2021

Monday 20th July 2020

By Bachem AG Learn More >

Bachem steps up Propofol production as CV-19 response

Tuesday 16th June 2020

By Bachem AG Learn More >

Bachem enters exclusive licensing agreement with Jitsubo for Molecular Hiving™ technology

Bachem enters exclusive licensing agreement with Jitsubo for Molecular Hiving™ technology

Tuesday 2nd June 2020

By Bachem AG Learn More >